• Phosphatase Inhibitor Cocktail 100X: Elevating Precision ...

  2025-09-29

  Explore how the Phosphatase Inhibitor Cocktail 100X revolutionizes protein phosphorylation preservation, advancing immunoblotting sample preparation and kinase activity assays. This article offers a molecular systems perspective, linking phosphorylation control to gene regulation and stem cell research.

• VER 155008: Unveiling Hsp70 Inhibition in Stress Granule ...

  2025-09-28

  Explore the advanced mechanistic role of VER 155008, a potent HSP 70 inhibitor, in modulating heat shock protein signaling and liquid-liquid phase separation within cancer research. This article uniquely integrates insights from recent phase separation studies and apoptosis assays, offering novel perspectives beyond standard applications.

• Plerixafor (AMD3100): Harnessing CXCR4 Inhibition for Pre...

  2025-09-27

  Explore the advanced scientific applications of Plerixafor (AMD3100), a potent CXCR4 chemokine receptor antagonist, in cancer research and immunology. This article uniquely examines mechanistic insights, comparative efficacy, and future directions for SDF-1/CXCR4 axis inhibition.

• RSL3 and the Ferroptosis Signaling Pathway: Systems Biolo...

  2025-09-26

  Explore how RSL3, a potent glutathione peroxidase 4 inhibitor, drives ferroptosis and ROS-mediated non-apoptotic cell death in cancer biology. This comprehensive article uniquely examines systems-level interactions, synthetic lethality with oncogenic RAS, and integrates recent apoptotic signaling discoveries for a deeper understanding of redox-targeted cancer therapeutics.

• 2'3'-cGAMP (sodium salt): Next-Generation STING Agonist f...

  2025-09-25

  Explore how 2'3'-cGAMP (sodium salt) advances STING-mediated innate immune response research. This article uniquely highlights translational strategies and experimental optimization for immunotherapy and antiviral studies.

• Phosbind Acrylamide: Transforming Phosphorylation Analysi...

  2025-09-24

  Discover how Phosbind Acrylamide revolutionizes protein phosphorylation analysis by enabling precise, antibody-free detection of phosphorylation-dependent mobility shifts in complex signaling pathways. Explore unique mechanistic insights and advanced applications that set this phosphate-binding reagent apart from traditional approaches.

• EZ Cap™ Firefly Luciferase mRNA: Enabling Advanced Biolum...

  2025-09-23

  Explore how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) advances bioluminescent reporter gene assays and mRNA delivery by integrating poly(A) tail mRNA stability, innate immune activation suppression, and Cap 1 mRNA capping structure for optimized research applications.

• Nebivolol Hydrochloride: Selective β1-Adrenoceptor Inhibi...

  2025-09-22

  This article examines Nebivolol hydrochloride as a highly selective β1-adrenoceptor antagonist, highlighting its application in β1-adrenergic receptor

• Biotin-16-UTP: Expanding Capabilities in RNA-Protein Inte...

  2025-09-19

  Biotin-16-UTP, a biotin-labeled uridine triphosphate analog, empowers advanced in vitro transcription RNA labeling for precise RNA detection, purification, and interaction studies. This article examines its unique applications in RNA-protein interaction studies, with a focus on emerging research in lncRNA biology.

• ARCA EGFP mRNA (5-moUTP): Enhancing Reporter mRNA Reliabi...

  2025-09-18

  Explore the scientific advantages of ARCA EGFP mRNA (5-moUTP) as a direct-detection reporter mRNA for fluorescence-based transfection control in mammalian cells, focusing on stability, innate immune suppression, and translational efficiency.

• Given that there are substitutions between

  2025-03-03

  

  Given that there are 132 substitutions between βAnc and the human β subunit, we wondered whether βAnc could replace the human β subunit in hybrid AChRs formed from ancestral and human subunits. We first confirmed that the β subunit is required for expression of human AChRs in HEK293 2272 by co-trans

• Given that there are substitutions between

  2025-03-03

  

  Given that there are 132 substitutions between βAnc and the human β subunit, we wondered whether βAnc could replace the human β subunit in hybrid AChRs formed from ancestral and human subunits. We first confirmed that the β subunit is required for expression of human AChRs in HEK293 Z-Ligustilide sy

• All scientific data over the years points

  2025-03-03

  

  All scientific data over the years points that 5α-reductase inhibitors undoubtedly are an effective treatment for BPH and associated LUTS, having a favorable risk-benefit profile. In contrast, although some studies indicated positive results, there is still no consensus about their use in BPH or PC

• Earlier studies showed that exposure of cells to

  2025-03-01

  

  Earlier studies showed that exposure of cells to IR caused ATM-dependent phosphorylation of 53BP1, as judged by electrophoretic mobility shift [24], [25], [26]. To date, the only known in vivo 53BP1 phosphorylation site(s) are Ser25 and possibly Ser29 [27]. In the course of our studies, we noticed t

• In previous years evidence emerged that inferred secondary m

  2025-03-01

  

  In previous years, evidence emerged that inferred secondary metabolites in plants might exhibit a potential arginase inhibition [36]. In a recent study, Pham and co-workers showed the inhibitory activity of chlorogenic G-1 (7) and piceatannol (8) (Fig. 3b) on mammalian arginase with IC50s of 10.6 a

15592 records 1/1040 page Next 12345 下5页 Last page